Published in J Immunol on July 01, 2002
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol (2008) 1.50
Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection. J Exp Med (2004) 1.47
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J Virol (2008) 1.35
Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med (2003) 1.34
CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol (2006) 1.27
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol (2006) 1.14
Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol (2006) 1.13
Pathways for antigen cross presentation. Springer Semin Immunopathol (2004) 1.10
MHC class I immune evasion in MCMV infection. Med Microbiol Immunol (2008) 1.10
A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS One (2011) 1.08
Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro. J Virol (2007) 1.05
Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1. J Immunol (2010) 1.03
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Med Microbiol Immunol (2008) 1.01
The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation. J Virol (2008) 1.01
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol (2004) 0.99
Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood (2008) 0.99
Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood (2007) 0.96
Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. J Virol (2003) 0.95
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. J Immunol (2011) 0.93
Viral sequestration of antigen subverts cross presentation to CD8(+) T cells. PLoS Pathog (2009) 0.93
Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice. J Immunol (2011) 0.91
Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes. J Virol (2009) 0.90
A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector. J Immunol (2013) 0.87
Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells. Med Microbiol Immunol (2012) 0.86
Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions. Med Microbiol Immunol (2012) 0.86
Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man. Cell Rep (2015) 0.84
A natural genetic variant of granzyme B confers lethality to a common viral infection. PLoS Pathog (2014) 0.84
The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins. J Virol (2009) 0.83
Viral infections in lung transplant recipients. Semin Respir Crit Care Med (2010) 0.83
IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS One (2012) 0.82
Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection. Med Microbiol Immunol (2012) 0.82
Viral infection transiently reverses activation receptor-mediated NK cell hyporesponsiveness in an MHC class I-independent mechanism. Eur J Immunol (2013) 0.80
Immune evasion proteins enhance cytomegalovirus latency in the lungs. J Virol (2009) 0.79
Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance. Front Immunol (2016) 0.78
Assessment of CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers. Methods Mol Biol (2013) 0.78
Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors. PLoS Pathog (2016) 0.78
A GMCSF and IL7 fusion cytokine leads to functional thymic-dependent T-cell regeneration in age-associated immune deficiency. Clin Transl Immunology (2015) 0.75
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina. Science (2002) 4.13
Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol (2009) 3.51
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol (2004) 3.42
Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity (2008) 3.33
High-resolution gene expression profiling for simultaneous kinetic parameter analysis of RNA synthesis and decay. RNA (2008) 3.13
Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg (2003) 3.12
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg (2007) 2.51
Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol (2009) 2.47
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med (2002) 2.37
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res (2009) 2.26
Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol (2006) 2.25
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Viral interference with antigen presentation. Nat Immunol (2002) 2.05
How do adjuvants work? Important considerations for new generation adjuvants. Immunity (2007) 2.01
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host. Cell Host Microbe (2008) 1.92
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe (2010) 1.91
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol (2005) 1.70
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J Immunol (2006) 1.67
Herpesvirus genetics has come of age. Trends Microbiol (2002) 1.66
Viruses know it all: new insights into IFN networks. Trends Immunol (2005) 1.62
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication. J Virol (2004) 1.59
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity (2002) 1.54
Is there still a role for total pancreatectomy? Ann Surg (2007) 1.52
Shedding light on the elusive role of endothelial cells in cytomegalovirus dissemination. PLoS Pathog (2011) 1.51
Assessment of functioning and disability after ischemic stroke. Stroke (2002) 1.48
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med (2009) 1.45
Cloning of herpesviral genomes as bacterial artificial chromosomes. Rev Med Virol (2003) 1.43
Functional domains of murine cytomegalovirus nuclear egress protein M53/p38. J Virol (2006) 1.41
Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog (2012) 1.40
HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog (2011) 1.40
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J Virol (2008) 1.35
An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J Immunol (2003) 1.34
Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med (2003) 1.34
Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay. J Virol (2006) 1.34
Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique. Virology (2003) 1.32
Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J Infect Dis (2003) 1.28
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol (2004) 1.28
CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol (2006) 1.27
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine (2004) 1.27
OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T Cells: A CD4-dependent mechanism. J Immunol (2007) 1.26
Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg (2005) 1.24
Invertebrate herbivory along a gradient of plant species diversity in extensively managed grasslands. Oecologia (2006) 1.24
Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells. Proc Natl Acad Sci U S A (2013) 1.23
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol (2004) 1.20
Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J Virol (2011) 1.20
Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol (2007) 1.20
Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg (2002) 1.16
Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog (2011) 1.16
Mesh shrinkage and pain in laparoscopic ventral hernia repair: a randomized clinical trial comparing suture versus tack mesh fixation. Surg Endosc (2010) 1.16
Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol (2005) 1.15
CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J Immunol (2009) 1.15
Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J Immunol (2006) 1.14
Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol (2006) 1.14
Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes. J Virol (2013) 1.13
Impact of invertebrate herbivory in grasslands depends on plant species diversity. Ecology (2010) 1.13
Viral interference with antigen presentation to CD8+ T cells: lessons from cytomegalovirus. Viral Immunol (2005) 1.12
Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J Virol (2004) 1.11
Mutagenesis of viral BACs with linear PCR fragments (ET recombination). Methods Mol Biol (2004) 1.10
MHC class I immune evasion in MCMV infection. Med Microbiol Immunol (2008) 1.10
An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality. Europace (2010) 1.08
Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS One (2010) 1.08
Management patterns and health care use after intracerebral hemorrhage. a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis (2003) 1.08
The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells. J Gen Virol (2002) 1.07
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. J Virol (2007) 1.07
Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection. Virology (2009) 1.04
The human cytomegalovirus UL45 gene product is a late, virion-associated protein and influences virus growth at low multiplicities of infection. J Gen Virol (2003) 1.04
Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol (2006) 1.04
Nitrogen supply affects arbuscular mycorrhizal colonization of Artemisia vulgaris in a phosphate-polluted field site. New Phytol (2005) 1.04